Retrovirology editorial board member  Jean-Luc Darlix participated this past weekend to help raise 6.3 million Euros for AIDS research. Jean-Luc has been involved in SIDACTION since its founding.  In the inset, he discusses his views on today’s HIV-1 research, the difficulties with the failed Merck vaccine study, and hopes for increased cooperation between research laboratories.